Therapy Areas
ForwardVue Pharma names new chief executive officer
28 July 2021 -

ForwardVue Pharma, an emerging biopharmaceutical company, announced on Tuesday that it has appointed Bob Katz as its new chief executive officer.

In the new role, Katz is to advance the pre-clinical development of potent long-acting anti-angiogenic molecules directed against diabetic eye disease and neovascular age related macular degeneration.

Katz is a seasoned life science executive. He was CEO and president of ContraMed and has held multiple C-level positions at venture-backed start-ups.



Related Headlines